Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence

被引：0

作者：

Julius Keyl ^{[1
]}

Philipp Keyl ^{[2
]}

Grégoire Montavon ^{[3
]}

René Hosch ^{[4
]}

Alexander Brehmer ^{[4
]}

Liliana Mochmann ^{[5
]}

Philipp Jurmeister ^{[6
]}

Gabriel Dernbach ^{[1
]}

Moon Kim ^{[1
]}

Sven Koitka ^{[3
]}

Sebastian Bauer ^{[3
]}

Nikolaos Bechrakis ^{[5
]}

Michael Forsting ^{[1
]}

Dagmar Führer-Sakel ^{[1
]}

Martin Glas ^{[7
]}

Viktor Grünwald ^{[8
]}

Boris Hadaschik ^{[9
]}

Johannes Haubold ^{[10
]}

Ken Herrmann ^{[11
]}

Stefan Kasper ^{[9
]}

Rainer Kimmig ^{[10
]}

Stephan Lang ^{[11
]}

Tienush Rassaf ^{[12
]}

Alexander Roesch ^{[7
]}

Dirk Schadendorf ^{[9
]}

Jens T. Siveke ^{[11
]}

Martin Stuschke ^{[9
]}

Ulrich Sure ^{[10
]}

Matthias Totzeck ^{[13
]}

Anja Welt ^{[9
]}

Marcel Wiesweg ^{[10
]}

Hideo A. Baba ^{[11
]}

Felix Nensa ^{[14
]}

Jan Egger ^{[8
]}

Klaus-Robert Müller ^{[9
]}

Martin Schuler ^{[10
]}

Frederick Klauschen ^{[11
]}

Jens Kleesiek ^{[15
]}

机构：

[1] University Hospital Essen (AöR),Institute for Artificial Intelligence in Medicine

[2] University Hospital Essen (AöR),Institute of Pathology

[3] Ludwig-Maximilians-University Munich,Institute of Pathology

[4] BIFOLD – Berlin Institute for the Foundations of Learning and Data,Machine Learning Group

[5] Technical University of Berlin,Department of Mathematics and Computer Science

[6] Freie Universität Berlin,Institute for Diagnostic and Interventional Radiology and Neuroradiology

[7] University Hospital Essen (AöR),Department of Medical Oncology

[8] University Hospital Essen (AöR),Medical Faculty

[9] University of Duisburg-Essen,West German Cancer Center

[10] University Hospital Essen (AöR),German Cancer Consortium (DKTK)

[11] Partner site University Hospital Essen (AöR),Department of Ophthalmology

[12] University Hospital Essen (AöR),Department of Endocrinology, Diabetes and Metabolism

[13] University Hospital Essen (AöR),Division of Clinical Neurooncology, Department of Neurology and Center for Translational Neuro

[14] University Duisburg-Essen, and Behavioral Sciences (C

[15] University Hospital Essen (AöR),TNBS), University Medicine Essen

[16] University Hospital Essen (AöR),Department of Urology

[17] University Hospital Essen (AöR),Department of Nuclear Medicine

[18] University Hospital Essen (AöR),Department of Gynecology and Obstetrics

[19] University Hospital Essen (AöR),Department of Otorhinolaryngology

[20] University Hospital Essen (AöR),Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen

[21] University of Duisburg-Essen,Department of Dermatology

[22] University of Duisburg-Essen,Research Alliance Ruhr, Research Center One Health

[23] DKFZ,Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen (AöR)

[24] University Hospital Essen (AöR),Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center

[25] University Hospital Essen (AöR),Department of Radiotherapy

[26] Korea University,Department of Neurosurgery and Spine Surgery

[27] MPI for Informatics,Department of Artificial Intelligence

[28] Berlin partner site,German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)

[29] Munich partner site,German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)

[30] Bavarian Cancer Research Center (BZKF),undefined

来源：

Nature Cancer | 2025年 / 6卷 / 2期

关键词：

D O I：

10.1038/s43018-024-00891-1

中图分类号：

学科分类号：

摘要：

Despite advances in precision oncology, clinical decision-making still relies on limited variables and expert knowledge. To address this limitation, we combined multimodal real-world data and explainable artificial intelligence (xAI) to introduce AI-derived (AID) markers for clinical decision support. We used xAI to decode the outcome of 15,726 patients across 38 solid cancer entities based on 350 markers, including clinical records, image-derived body compositions, and mutational tumor profiles. xAI determined the prognostic contribution of each clinical marker at the patient level and identified 114 key markers that accounted for 90% of the neural network’s decision process. Moreover, xAI enabled us to uncover 1,373 prognostic interactions between markers. Our approach was validated in an independent cohort of 3,288 patients with lung cancer from a US nationwide electronic health record-derived database. These results show the potential of xAI to transform the assessment of clinical variables and enable personalized, data-driven cancer care.

引用

页码：307 / 322

页数：15

共 50 条

[31] Real-world treatment outcomes of metastatic pancreatic cancer in Japan: Tokushukai REAl-world Data project 03 (TREAD 03)
Shimoyama, Rai
Imamura, Yoshinori
Uryu, Kiyoaki
Mase, Takahiro
Fujimura, Yoshiaki
Hayashi, Maki
Ohtaki, Megu
Otani, Keiko
Shinozaki, Nobuaki
Minami, Hironobu
ANNALS OF ONCOLOGY, 2022, 33 : S484 - S485
[32] Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan
Kanda, Eiichiro
Epureanu, Bogdan I.
Adachi, Taiji
Tsuruta, Yuki
Kikuchi, Kan
Kashihara, Naoki
Abe, Masanori
Masakane, Ikuto
Nitta, Kosaku
PLOS ONE, 2020, 15 (05):
[33] Validating the Generalizability of Ophthalmic Artificial Intelligence Models on Real-World Clinical Data
Rashidisabet, Homa
Sethi, Abhishek
Jindarak, Ponpawee
Edmonds, James
Chan, R. V. Paul
Leiderman, Yannek I.
Vajaranant, Thasarat Sutabutr
Yi, Darvin
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2023, 12 (11):
[34] Digital Therapeutics: Virtual Coaching Powered by Artificial Intelligence on Real-World Data
op den Akker, Harm
Cabrita, Miriam
Pnevmatikakis, Aristodemos
FRONTIERS IN COMPUTER SCIENCE, 2021, 3
[35] Pan-cancer diagnostic consensus through searching archival histopathology images using artificial intelligence
Kalra, Shivam
Tizhoosh, H. R.
Shah, Sultaan
Choi, Charles
Damaskinos, Savvas
Safarpoor, Amir
Shafiei, Sobhan
Babaie, Morteza
Diamandis, Phedias
Campbell, Clinton J. V.
Pantanowitz, Liron
NPJ DIGITAL MEDICINE, 2020, 3 (01)
[36] Artificial intelligence-based pulmonary embolism classification: Development and validation using real-world data
da Silva, Luan Oliveira
da Silva, Maria Carolina Bueno
Ribeiro, Guilherme Alberto Sousa
de Camargo, Thiago Fellipe Ortiz
dos Santos, Paulo Victor
Mendes, Giovanna de Souza
de Paiva, Joselisa Peres Queiroz
Soares, Anderson da Silva
Reis, Marcio Rodrigues da Cunha
Loureiro, Rafael Maffei
Calixto, Wesley Pacheco
PLOS ONE, 2024, 19 (08):
[37] Pan-cancer diagnostic consensus through searching archival histopathology images using artificial intelligence
Shivam Kalra
H. R. Tizhoosh
Sultaan Shah
Charles Choi
Savvas Damaskinos
Amir Safarpoor
Sobhan Shafiei
Morteza Babaie
Phedias Diamandis
Clinton J. V. Campbell
Liron Pantanowitz
npj Digital Medicine, 3
[38] Timely and comprehensive real-world data for optimizing lung cancer treatment and outcomes for Australians
Tang, Monica
Daniels, Benjamin
Coory, Michael
Pearson, Sallie-Anne
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (03) : 413 - 414
[39] Pan-cancer analysis of clinical acquired resistance (AR) in BRAF-driven real-world cases
Pietrantonio, F.
Lee, J.
Boussemart, L.
Schinke, C.
Srkalovic, G.
Madison, R.
Ross, J. S.
Miller, V. A.
Alexander, B. M.
Ali, S. M.
Schrock, A. B.
Daniels, G. A.
ANNALS OF ONCOLOGY, 2019, 30 : 762 - +
[40] A Study on Treatment and Characteristics of Prostate Cancer Patients Using Real-World Data
Miranda, Jamilette
Lilja, Birgitta
Wettermark, Bjoern
Ljunggren, Gunnar
Henriksson, Roger
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 533 - 533

← 1 2 3 4 5 →